magnesium sulfate has been researched along with Central Nervous System Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brookfield, KF; Vinson, A | 1 |
Crowther, CA; Doyle, LW; Marret, S; Middleton, P; Rouse, D | 1 |
Beucher, G; Dreyfus, M | 1 |
Marret, S | 1 |
Crowther, CA; Doyle, LW; Marret, S; Middleton, P | 1 |
Clark, RF; Manoguerra, A; Nordt, SP; Smith, D; Turchen, S; Williams, SR | 1 |
Ekblad, U; Grönlund, J; Kero, P; Rantonen, T; Rikalainen, H; Välimäki, I | 1 |
3 review(s) available for magnesium sulfate and Central Nervous System Disease
Article | Year |
---|---|
Magnesium sulfate use for fetal neuroprotection.
Topics: Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment | 2019 |
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2009 |
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Topics: Central Nervous System Diseases; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic | 2007 |
4 other study(ies) available for magnesium sulfate and Central Nervous System Disease
Article | Year |
---|---|
[Efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia].
Topics: Calcium Channel Blockers; Central Nervous System Diseases; Eclampsia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Treatment Outcome | 2010 |
[Magnesium sulphate: an improvement in the field of preterm infant neuroprotection].
Topics: Central Nervous System Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Premature Birth | 2010 |
Hypermagnesemia following an acute ingestion of Epsom salt in a patient with normal renal function.
Topics: Central Nervous System Diseases; Female; Humans; Magnesium Sulfate; Middle Aged; Muscular Diseases; Musculoskeletal System; Poisoning | 1996 |
Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up.
Topics: Adult; Analysis of Variance; Birth Weight; Central Nervous System Diseases; Female; Follow-Up Studies; Hospitalization; Humans; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Magnesium Sulfate; Male; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Prenatal Care; Prenatal Exposure Delayed Effects; Retrospective Studies; Ritodrine; Statistics, Nonparametric; Tocolytic Agents; Ultrasonography | 1999 |